Trial Site Detail
Drug: |
Temozolomide |
|||
|---|---|---|---|---|
Trial: |
Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Active, not recruiting |
|||
Fox Chase Cancer Center333 Cottman Ave |
Principal Investigator: |
Margeret von Mehren, M.D. |
|---|---|
Contact: |
Linda Thibodeau 215-728-2207 Linda.Thibodeau@fccc.edu |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
Fox Chase Cancer Center Website: |
https://www.protonet.fccc.edu/fccc/pims/ |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.